Enterprise Products Partners L. vs SLB Limited — Stock Comparison
Q·Score Breakdown
5.6
Neutral
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
EPD
Forward P/E of 12.1× is low relative to sector peers.
⚠ revenue declining 7% year-over-year.
SLB
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ earnings contracting 14% year-over-year.
Analyst Consensus
HOLD
Target $40.45 (+6.4%)
20 analysts
BUY
Target $60.33 (+6.0%)
28 analysts
Fundamentals
EPD
SLB
14.1×
Trailing P/E
25.1×
12.1×
Forward P/E
17.0×
11.4%
Profit Margin
9.3%
14.3%
Gross Margin
17.8%
—
ROE
14.1%
-6.7%
Revenue Growth
2.7%
6.5%
Earnings Growth
-13.8%
0.53
Beta
0.69
—
Price / Book
—
$82.2B
Market Cap
$85.1B
$30 – $40
52-Week Range
$32 – $57
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →